Wuhan Institute of Biological Products Co., Ltd.
Establishment time : 1967
website : http://www.wibp.com.cn/
Main Product : Vaccines, biological products
Company Profile
Wuhan Institute of Biological Products Co., Ltd. is a leading manufacturer of vaccines and biological products in China. With a history dating back to 1967, the company has grown to become a major player in the industry. They serve both domestic and international markets, offering a wide range of high-quality products. Despite facing competition from other companies, Wuhan Institute of Biological Products Co., Ltd. remains a trusted name in the field.
Hualan Biological Engineering Inc.
Establishment time : 1993
website : www.hualanbio.com
Main Product : Vaccines, blood products, diagnostic reagents
Company Profile
Hualan Biological Engineering Inc. is a leading biotechnology company specializing in the research, development, and production of vaccines, blood products, and diagnostic reagents. With a strong presence in the Chinese market and expanding into international markets, Hualan is known for its high-quality products and innovative research. Founded in 1993, the company has grown to become a major player in the biotech industry, with a large production capacity and a diverse product portfolio.
Shanghai Sanyou Biopharmaceuticals Co., Ltd.
Establishment time : 2008
website : www.sanyou-biopharma.com
Main Product : Biopharmaceuticals
Company Profile
Shanghai Sanyou Biopharmaceuticals Co., Ltd. is a leading biopharmaceutical company established in 2008. We specialize in the research, development, and production of high-quality biopharmaceutical products. With a strong presence in both the Chinese and international markets, we are committed to providing innovative solutions to improve healthcare outcomes. Our medium-sized company prides itself on our competitive edge and dedication to advancing the field of biopharmaceuticals. Visit our website at www.sanyou-biopharma.com for more information.
Beijing Biocytogen Co., Ltd.
Establishment time : 2009
website : www.biocytogen.com
Main Product : Gene-targeted animal models, preclinical drug development services
Company Profile
Beijing Biocytogen Co., Ltd. is a biotechnology company specializing in the development of gene-targeted animal models and preclinical drug development services. Established in 2009, the company has grown to over 300 employees and serves markets worldwide, with a strong presence in North America, Europe, and Asia. With a reputation for cutting-edge technology and expertise, Biocytogen is a leader in its field, providing innovative solutions for drug discovery and development. Visit www.biocytogen.com for more information.
Changchun Zhuoyi Biological Co., Ltd
Company Profile
Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.
Shenzhen Kangtai Biological Products Co., Ltd.
Establishment time : 1992
website : www.kangtaibiotech.com
Main Product : vaccines, biological products
Company Profile
Shenzhen Kangtai Biological Products Co., Ltd. was founded in 1992 and has grown to become a leading manufacturer of vaccines and biological products. With a large company size and strong research and development capabilities, Kangtai serves both the domestic Chinese market and international markets. The company is known for its high-quality products and competitive position in the industry. Visit their website at www.kangtaibiotech.com for more information.
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.
Establishment time : 1997
website : www.baiyunshan.com
Main Product : Pharmaceutical products, health supplements, herbal medicines
Company Profile
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. is a leading pharmaceutical company in China, known for its high-quality products and commitment to innovation. With a history dating back to 1997, the company has grown to become a major player in the industry, serving markets in China, Asia, and beyond. Their diverse product portfolio includes pharmaceuticals, health supplements, and herbal medicines, catering to a wide range of consumer needs. Despite facing strong competition, the company continues to thrive due to its focus on quality, research, and development. Visit their website at www.baiyunshan.com for more information.
Changchun BCHT Biotechnology Co., Ltd.
Establishment time : June 2004
website : www.bchtbiotech.com
Main Product : Biological products, vaccines, diagnostic reagents
Company Profile
Changchun BCHT Biotechnology Co., Ltd. is a reputable biotechnology company founded in 2004. With a wide range of biological products, vaccines, and diagnostic reagents, the company has established itself as a key player in the industry. With a strong presence in both domestic and international markets, BCHT Biotechnology continues to grow and innovate in the field of biotechnology.
May 29, 2024
